₹178.2*
MRP ₹198
10% off
₹168.3*
MRP ₹198
15% CB
₹29.7 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Prescription drugWhats That
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
Also Explore
संरचना :
IBANDRONIC ACID-50MG
निर्माता/विपणनकर्ता :
Natco Pharma Ltd
सेवन प्रकार :
मौखिक
वापसी नीति :
वापसी योग्य नहीं
इस तारीख या इसके बाद समाप्त :
Jan-27
Drug-Drug Interactions
Drug-Drug Interactions
Login/Sign Up
How does the drug interact with Iban Plus Tablet:
Taking Tacrolimus and Iban Plus Tablet together may increase the risk of kidney problems.
How to manage the interaction:
Although taking Tacrolimus and Iban Plus Tablet together can result in an interaction, it can be taken if a doctor has prescribed it. However, consult the doctor immediately if you experience symptoms such as nausea, vomiting, loss of hunger, increased or decreased urination, sudden weight gain or weight loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm. Do not discontinue any medications without consulting a doctor.
Taking Tacrolimus and Iban Plus Tablet together may increase the risk of kidney problems.
How to manage the interaction:
Although taking Tacrolimus and Iban Plus Tablet together can result in an interaction, it can be taken if a doctor has prescribed it. However, consult the doctor immediately if you experience symptoms such as nausea, vomiting, loss of hunger, increased or decreased urination, sudden weight gain or weight loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm. Do not discontinue any medications without consulting a doctor.
How does the drug interact with Iban Plus Tablet:
Co-administration of Tenofovir alafenamide with Iban Plus Tablet can increase the risk of kidney damage.
How to manage the interaction:
Taking Iban Plus Tablet with Tenofovir alafenamide together can result in an interaction, but it can be taken if a doctor has advised it. However, if you experience symptoms such as nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or loss, fluid retention, swelling, shortness of breath, pain in the muscles, weakness, tiredness, dizziness, confusion, and irregular heart rhythm, consult a doctor. Do not stop using any medications without consulting a doctor.
Co-administration of Tenofovir alafenamide with Iban Plus Tablet can increase the risk of kidney damage.
How to manage the interaction:
Taking Iban Plus Tablet with Tenofovir alafenamide together can result in an interaction, but it can be taken if a doctor has advised it. However, if you experience symptoms such as nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or loss, fluid retention, swelling, shortness of breath, pain in the muscles, weakness, tiredness, dizziness, confusion, and irregular heart rhythm, consult a doctor. Do not stop using any medications without consulting a doctor.
Ibandronic acidMetrizamide
Severe
How does the drug interact with Iban Plus Tablet:
Co-administration of Metrizamide with Iban Plus Tablet may increase the risk or severity of kidney damage
How to manage the interaction:
Taking Iban Plus Tablet with Metrizamide together can result in an interaction, but it can be taken if a doctor has advised it. However, consult a doctor immediately if you experience any symptoms such as nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or weight loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm. Do not discontinue any medications without consulting a doctor.
Co-administration of Metrizamide with Iban Plus Tablet may increase the risk or severity of kidney damage
How to manage the interaction:
Taking Iban Plus Tablet with Metrizamide together can result in an interaction, but it can be taken if a doctor has advised it. However, consult a doctor immediately if you experience any symptoms such as nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or weight loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm. Do not discontinue any medications without consulting a doctor.
How does the drug interact with Iban Plus Tablet:
Co-administration of Deferasirox with Iban Plus Tablet (oral form) may raise your chance of experiencing gastrointestinal (stomach & intestine) bleeding and ulcers.
How to manage the interaction:
Co-administration of Iban Plus Tablet with Deferasirox can result in an interaction, but it can be taken if a doctor has advised it. If you have symptoms like stomach pain, bloating, dizziness, or black stools, it's essential to consult a doctor. Do not stop using any medications without a doctor's advice.
Co-administration of Deferasirox with Iban Plus Tablet (oral form) may raise your chance of experiencing gastrointestinal (stomach & intestine) bleeding and ulcers.
How to manage the interaction:
Co-administration of Iban Plus Tablet with Deferasirox can result in an interaction, but it can be taken if a doctor has advised it. If you have symptoms like stomach pain, bloating, dizziness, or black stools, it's essential to consult a doctor. Do not stop using any medications without a doctor's advice.
Ibandronic acidIohexol
Severe
How does the drug interact with Iban Plus Tablet:
Co-administration of Iohexol with Iban Plus Tablet may increase the risk of kidney damage.
How to manage the interaction:
There may be a possibility of interaction between Iban Plus Tablet and Iohexol, but it can be taken if prescribed by a doctor. However, contact a doctor immediately if you experience any symptoms such as nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or weight loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm. Do not discontinue any medications without consulting a doctor.
Co-administration of Iohexol with Iban Plus Tablet may increase the risk of kidney damage.
How to manage the interaction:
There may be a possibility of interaction between Iban Plus Tablet and Iohexol, but it can be taken if prescribed by a doctor. However, contact a doctor immediately if you experience any symptoms such as nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or weight loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm. Do not discontinue any medications without consulting a doctor.
How does the drug interact with Iban Plus Tablet:
Co-administration of Human immunoglobulin with Iban Plus Tablet may raise the risk of kidney problems.
How to manage the interaction:
Although there is a possible interaction between Human immunoglobulin and Iban Plus Tablet, you can take these medicines together if prescribed by a doctor. However, if you experience nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, or an irregular heart rhythm, consult a doctor. Do not discontinue any medications without consulting a doctor.
Co-administration of Human immunoglobulin with Iban Plus Tablet may raise the risk of kidney problems.
How to manage the interaction:
Although there is a possible interaction between Human immunoglobulin and Iban Plus Tablet, you can take these medicines together if prescribed by a doctor. However, if you experience nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, or an irregular heart rhythm, consult a doctor. Do not discontinue any medications without consulting a doctor.
Severe
How does the drug interact with Iban Plus Tablet:
Co-administration of Cidofovir with Iban Plus Tablet can increase the risk of kidney problems.
How to manage the interaction:
Although taking Iban Plus Tablet and Cidofovir together can cause an interaction, it can be taken if your doctor has suggested it. However, if you experience nausea, vomiting, loss of hunger, increased or decreased urination, sudden weight gain or loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, or an irregular heart rhythm, consult a doctor. Do not discontinue any medications without consulting a doctor.
Co-administration of Cidofovir with Iban Plus Tablet can increase the risk of kidney problems.
How to manage the interaction:
Although taking Iban Plus Tablet and Cidofovir together can cause an interaction, it can be taken if your doctor has suggested it. However, if you experience nausea, vomiting, loss of hunger, increased or decreased urination, sudden weight gain or loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, or an irregular heart rhythm, consult a doctor. Do not discontinue any medications without consulting a doctor.
Severe
How does the drug interact with Iban Plus Tablet:
Co-administration of Sirolimus and Iban Plus Tablet may cause an increase in the risk or severity of kidney damage.
How to manage the interaction:
Although taking Iban Plus Tablet and Sirolimus together may lead to an interaction, it can be taken if a doctor has suggested it. However, if you experience symptoms such as nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or loss, fluid retention, swelling, shortness of breath, pain in the muscles, weakness, tiredness, dizziness, confusion, and irregular heart rhythm, consult a doctor. Do not stop using any medication without consulting a doctor.
Co-administration of Sirolimus and Iban Plus Tablet may cause an increase in the risk or severity of kidney damage.
How to manage the interaction:
Although taking Iban Plus Tablet and Sirolimus together may lead to an interaction, it can be taken if a doctor has suggested it. However, if you experience symptoms such as nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or loss, fluid retention, swelling, shortness of breath, pain in the muscles, weakness, tiredness, dizziness, confusion, and irregular heart rhythm, consult a doctor. Do not stop using any medication without consulting a doctor.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Product Substitutes
शराब
सावधानी
यह ज्ञात नहीं है कि शराब इबान प्लस टैबलेट 1 को प्रभावित करती है या नहीं। कृपया अपने चिकित्सक से परामर्श करें।
गर्भावस्था
सावधानी
इबान प्लस टैबलेट 1 गर्भावस्था श्रेणी C से संबंधित है। अगर आप गर्भवती हैं तो अपने चिकित्सक से सलाह लें। आपका डॉक्टर इबान प्लस टैबलेट 1 तभी लिखेंगे जब लाभ जोखिमों से ज़्यादा हों।
स्तनपान
सावधानी
यह ज्ञात नहीं है कि इबान प्लस टैबलेट 1 स्तन के दूध में गुजरता है या नहीं। अगर आप स्तनपान करा रही हैं तो इस दवा को लेने से पहले अपने चिकित्सक से सलाह लें।
ड्राइविंग
यदि निर्धारित हो तो सुरक्षित
इबान प्लस टैबलेट 1 का ड्राइव करने की क्षमता पर कोई या नगण्य प्रभाव नहीं पड़ता है।
जिगर
सावधानी
यदि आपको लिवर की बीमारी है या इससे संबंधित कोई चिंता है तो इबान प्लस टैबलेट 1 लेने से पहले कृपया अपने चिकित्सक से परामर्श करें।
गुर्दा
सावधानी
गंभीर गुर्दे की दुर्बलता वाले लोगों के लिए इबान प्लस टैबलेट 1 की सिफारिश नहीं की जाती है। अगर आपको किडनी की बीमारी है या इससे संबंधित कोई चिंता है तो कृपया अपने डॉक्टर से सलाह लें।
बच्चे
असुरक्षित
18 साल से कम उम्र के बच्चों के लिए इबान प्लस टैबलेट 1 की सिफारिश नहीं की जाती है क्योंकि सुरक्षा और प्रभावशीलता स्थापित नहीं की गई है।
Have a query?
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Author Details
